Mark A. Sirgo - Aug 23, 2021 Form 4 Insider Report for BIODELIVERY SCIENCES INTERNATIONAL INC (BDSI)

Role
Director
Signature
/s/ Mark A. Sirgo
Stock symbol
BDSI
Transactions as of
Aug 23, 2021
Transactions value $
$180,480
Form type
4
Date filed
8/25/2021, 04:37 PM
Previous filing
Aug 23, 2021
Next filing
Sep 8, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDSI Common Stock Options Exercise $0 +4K +0.36% $0.00 1.11M Aug 23, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSI Stock Options (right to buy) Award $180K +48K $3.76 48K Aug 23, 2021 Common Stock 48K $3.76 Direct F2
transaction BDSI Restricted Stock Units Award $0 +8K $0.00 8K Aug 23, 2021 Common Stock 8K $0.00 Direct F1
transaction BDSI Restricted Stock Units Options Exercise $0 -4K -50% $0.00 4K Aug 23, 2021 Common Stock 4K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units ("RSUs") were issued to the Reporting Person on August 23, 2021 (the "Effective Date"), as compensation for service on the Company's board of directors. The RSUs vest as follows: (i) 4,000 RSUs vested in the first open window following the filing of the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2021, and (ii) 4,000 RSUs will vest upon the earlier of (i) the first anniversary of the Effective Date or (ii) the Company's 2022 Annual Meeting of Stockholders.
F2 The stock options ("options") were issued to the Reporting Person on the Effective Date, as compensation for service on the Company's board of directors. The options vest as follows: (i) 24,000 options vested in the first open window following the filing of the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2021, and (ii) 24,000 options will vest upon the earlier of (i) the first anniversary of the Effective Date or (ii) the Company's 2022 Annual Meeting of Stockholders.